Effects of MTor and Insulin Receptor Inhibition in Tamoxifen Resistant Breast Cancer Cells

被引：0
|
作者：
Mietzsch, F. [1 ]
Sinn, H. P. [1 ]
Schirmacher, P. [1 ]
Aulmann, S. [1 ]
机构：
[1] Univ Heidelberg, Inst Pathol, D-6900 Heidelberg, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S125 / S125
页数：1
相关论文
共 50 条
  • [1] Inhibition of angiogenesis by quercetin in tamoxifen-resistant breast cancer cells
    Oh, Soo Jin
    Kim, Ok
    Lee, Jong Suk
    Kim, Jung-Ae
    Kim, Mi Ra
    Choi, Hong Seok
    Shim, Jeong-Hyun
    Kang, Keon Wook
    Kim, Young Chul
    FOOD AND CHEMICAL TOXICOLOGY, 2010, 48 (11) : 3227 - 3234
  • [2] The effect of silencing the insulin-like growth factor receptor on tamoxifen sensitive and tamoxifen resistant breast cancer cells.
    McVittie, CJ
    Khalaf, S
    Ogunkolade, BW
    Bustin, SA
    Jenkins, PJ
    Carpenter, R
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S195 - S195
  • [3] mTOR inhibition in the treatment of resistant breast cancer
    Rodriguez, M. J.
    Perrone, M. C.
    Riggio, M.
    Novaro, V.
    ANNALS OF ONCOLOGY, 2019, 30
  • [4] Inhibition of O-GIcNAc transferase in tamoxifen resistant breast cancer cells
    Barkovskaya, Anna
    Prasmickaite, Lina
    Mills, Ian G.
    Mmlandsmo, Gunhild M.
    Moestue, Siver A.
    Itkonen, Harri M.
    CANCER RESEARCH, 2016, 76
  • [5] Inhibition of Metabolism as a Therapeutic Option for Tamoxifen-Resistant Breast Cancer Cells
    Steifensand, Friederike
    Gallwas, Julia
    Bauerschmitz, Gerd
    Gruendker, Carsten
    CELLS, 2021, 10 (09)
  • [6] Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
    Seo Yun Moon
    Heejin Lee
    Seoree Kim
    Ji Hyung Hong
    Sang Hoon Chun
    Hee Yeon Lee
    Keunsoo Kang
    Ho Shik Kim
    Hye Sung Won
    Yoon Ho Ko
    BMC Cancer, 21
  • [7] Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
    Moon, Seo Yun
    Lee, Heejin
    Kim, Seoree
    Hong, Ji Hyung
    Chun, Sang Hoon
    Lee, Hee Yeon
    Kang, Keunsoo
    Kim, Ho Shik
    Won, Hye Sung
    Ko, Yoon Ho
    BMC CANCER, 2021, 21 (01)
  • [8] Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt activity
    DeGraffenried, LA
    Friedrichs, WE
    Russell, DH
    Donzis, EJ
    Middleton, AK
    Silva, JM
    Roth, RA
    Hidalgo, M
    CLINICAL CANCER RESEARCH, 2004, 10 (23) : 8059 - 8067
  • [9] Sorafenib and nilotinib resensitize tamoxifen resistant breast cancer cells to tamoxifen treatment via estrogen receptor α
    Pedersen, Astrid M.
    Thrane, Susan
    Lykkesfeldt, Anne E.
    Yde, Christina W.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (05) : 2167 - 2175
  • [10] mTOR inhibition in hormone-resistant breast cancer
    Sharma, Sharan Prakash
    LANCET ONCOLOGY, 2012, 13 (06): : E239 - E239
12345